The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2024 | The current limitations of mouse models of CLL: moving towards humanized models
Elisa Ten Hacken, PhD, Weill Cornell Medicine, New York City, NY, discusses the current limitations of mouse models of chronic lymphocytic leukemia (CLL), particularly for testing immunotherapeutics. She emphasizes the need for humanized mouse models, which would involve transplanting patient stem cells to create a more relevant testing environment for immunotherapeutic efficacy against human cells. This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
